Vical to Present VL-2397 Data at the June ASM Microbe 2017 Meeting
May 23, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, May 23, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company will present clinical data on its completed Phase 1 trial of its novel antifungal,...
Vical Reports First Quarter 2017 Financial Results
May 15, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, May 15, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months ended March 31, 2017. Net loss for the first quarter of 2017 was...
Vical Announces News Release and Conference Call Schedule for First Quarter 2017 Financial Results
May 08, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, May 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended March 31, 2017, before the...
Vical Highlights Successful Outcome of Phase 1 Trial of VL-2397 Novel Antifungal During its Research and Development Day
May 02, 2017 16:36 ET
|
Vical Incorporated
SAN DIEGO, May 02, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today held its virtual Research and Development day for investors and analysts. The company provided an update on its...
Vical to Host Virtual Research & Development Day on May 2, 2017
April 24, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, April 24, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that it will host a virtual Research & Development Day for analysts, investors and media on...
Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial
April 19, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, April 19, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that it has completed the target enrollment of 225 subjects in a Phase 2 trial of its therapeutic...
Vical to Provide Company Update at the 29th Annual ROTH Conference
March 10, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, March 10, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at...
Vical to Provide Company Update at BIO Asia International Conference
March 09, 2017 07:00 ET
|
Vical Incorporated
SAN DIEGO, March 09, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at...
Vical Reports Fourth Quarter 2016 Financial Results
March 09, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, March 09, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three and twelve months ended December 31, 2016. Net loss for the fourth...
Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2016 Financial Results
March 02, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, March 02, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended December 31, 2016, before the...